Precigen is a biotechnology company in the healthcare sector on NASDAQ, led by Dr. Helen Sabzevari, with a market cap of $1.3B. As of Q3 2025, 31% of shares are held by 162 institutional investors, with Patient Capital Management, LLC as the largest holder at 7.5%.
Overview of institutional ownership in PGEN as of Q3 2025 with a market cap of $1.2B
Based on market cap of $1.2B as of Q3 2025. Institutional (non-HF) excludes hedge funds to avoid double counting.
Institutions with the largest positions in PGEN as of Q3 2025
| Institution | Position Value |
|---|---|
P Patient Capital Management, LLC Hedge Fund•Value | $87.1M 3.48% of portfolio |
T TANG CAPITAL MANAGEMENT LLC Institution | $40.8M 1.61% of portfolio |
B BlackRock, Inc. Institution | $40.0M 0.00% of portfolio |
VANGUARD GROUP INC Institution | $29.4M 0.00% of portfolio |
STATE STREET CORP Institution | $14.8M 0.00% of portfolio |
GEODE CAPITAL MANAGEMENT LLC ETF Provider | $12.7M 0.00% of portfolio |
IRIDIAN ASSET MANAGEMENT LLC/CT Hedge Fund•Long/Short | $12.1M 4.75% of portfolio |
Point72 Asset Management, L.P. Hedge Fund•Multi-Strategy | $9.0M 0.02% of portfolio |
CITADEL ADVISORS LLC Hedge Fund•Multi-Strategy | $8.9M 0.01% of portfolio |
BANK OF AMERICA CORP /DE/ Institution | $8.2M 0.00% of portfolio |
Institutional buying and selling activity for PGEN in Q3 2025
| Institution | Net Bought |
|---|---|
T TANG CAPITAL MANAGEMENT LLC Institution | +$40.8M +12.4M shares |
P Patient Capital Management, LLC Hedge Fund•Value | +$33.5M +10.2M shares |
Point72 Asset Management, L.P. Hedge Fund•Multi-Strategy | +$9.0M +2.7M shares |
CITADEL ADVISORS LLC Hedge Fund•Multi-Strategy | +$7.8M +2.4M shares |
DRIEHAUS CAPITAL MANAGEMENT LLC Hedge Fund•Event Driven | +$6.7M +2.0M shares |
BANK OF AMERICA CORP /DE/ Institution | +$5.5M +1.7M shares |
STATE STREET CORP Institution | +$4.8M +1.5M shares |
B BlackRock, Inc. Institution | +$3.3M +1.0M shares |
Boxer Capital Management, LLC Hedge Fund•Long/Short | +$2.8M +850.0K shares |
A ADAGE CAPITAL PARTNERS GP LLC Institution | +$2.8M +-10.4M shares |
| Institution | Net Sold |
|---|---|
IRIDIAN ASSET MANAGEMENT LLC/CT Hedge Fund•Long/Short | −$2.0M −611.7K shares |
Schonfeld Strategic Advisors LLC Hedge Fund•Multi-Strategy | −$1.9M −581.9K shares |
R ROYAL BANK OF CANADA Institution | −$971.5K −295.3K shares |
FMR LLC Institution | −$715.8K −217.6K shares |
F Fore Capital, LLC Institution | −$485.4K −341.8K shares |
CWM Advisors, LLC ETF Provider | −$466.0K −141.6K shares |
VANGUARD GROUP INC Institution | −$420.3K −127.7K shares |
−$411.3K −125.0K shares | |
RENAISSANCE TECHNOLOGIES LLC Hedge Fund•Quant | −$408.1K −287.4K shares |
PRUDENTIAL FINANCIAL INC Institution | −$355.3K −108.0K shares |
Institutions that initiated new positions or completely exited PGEN in Q3 2025
| Institution | Position Value |
|---|---|
Boxer Capital Management, LLC Hedge Fund•Long/Short | $2.8M 850.0K shares |
EAM Investors, LLC Long Only Manager | $2.2M 677.4K shares |
Lansing Street Advisors RIA/Wealth | $1.8M 547.0K shares |
Voleon Capital Management LP Hedge Fund•Quant | $482.5K 146.7K shares |
B Brevan Howard Capital Management LP Institution | $407.1K 123.7K shares |
Jain Global LLC Hedge Fund•Multi-Strategy | $333.3K 101.3K shares |
Point72 Ltd RIA/Wealth | $100.7K 30.6K shares |
Hudson Bay Capital Management LP Hedge Fund•Multi-Strategy | $66.4K 20.2K shares |
Susquehanna Portfolio Strategies, LLC Private Equity | $62.6K 19.0K shares |
Atom Investors LP Hedge Fund•Market Neutral | $48.8K 14.8K shares |
| Institution | Previous Position |
|---|---|
F Fore Capital, LLC Institution | $485.4K 341.8K shares |
RENAISSANCE TECHNOLOGIES LLC Hedge Fund•Quant | $408.1K 287.4K shares |
G GROUP ONE TRADING, L.P. Institution | $264.6K 186.3K shares |
GSA CAPITAL PARTNERS LLP Hedge Fund•Quant | $259.6K 182.8K shares |
TUDOR INVESTMENT CORP ET AL Hedge Fund•Multi-Strategy | $101.5K 71.5K shares |
Graham Capital Management, L.P. Hedge Fund•Multi-Strategy | $84.4K 59.4K shares |
W WOLVERINE TRADING, LLC Institution | $38.7K 27.3K shares |
R Squared Ltd Private Equity | $23.4K 16.5K shares |
CHIRON CAPITAL MANAGEMENT, LLC RIA/Wealth | $18.5K 13.1K shares |
Allspring Global Investments Holdings, LLC Long Only Manager | $16.2K 11.1K shares |
Institutions with the largest Call and Put options positions in PGEN as of Q3 2025
| Institution | Position Value |
|---|---|
Caption Management, LLC Hedge Fund•Long/Short | $11.2M 34.0K contracts |
SUSQUEHANNA INTERNATIONAL GROUP, LLP Private Equity | $7.2M 21.8K contracts |
CITADEL ADVISORS LLC Hedge Fund•Multi-Strategy | $1.7M 5.1K contracts |
J JANE STREET GROUP, LLC Institution | $1.3M 4.1K contracts |
C Cubist Systematic Strategies, LLC Institution | $320.8K 975.0 contracts |
L LPL Financial LLC Institution | $32.9K 100.0 contracts |
W WOLVERINE TRADING, LLC Institution | - - contracts |
| Institution | Position Value |
|---|---|
Caption Management, LLC Hedge Fund•Long/Short | $3.7M 11.3K contracts |
SUSQUEHANNA INTERNATIONAL GROUP, LLP Private Equity | $2.0M 6.0K contracts |
CITADEL ADVISORS LLC Hedge Fund•Multi-Strategy | $841.9K 2.6K contracts |
J JANE STREET GROUP, LLC Institution | $257.3K 782.0 contracts |
W WOLVERINE TRADING, LLC Institution | - - contracts |
Institutions with PGEN as the highest % of their portfolio as of Q3 2025
| Institution | Portfolio Weight |
|---|---|
IRIDIAN ASSET MANAGEMENT LLC/CT Hedge Fund•Long/Short | 4.75% $12.1M |
P Patient Capital Management, LLC Hedge Fund•Value | 3.48% $87.1M |
T TANG CAPITAL MANAGEMENT LLC Institution | 1.61% $40.8M |
Diametric Capital, LP Hedge Fund•Long/Short | 1.21% $3.2M |
Boxer Capital Management, LLC Hedge Fund•Long/Short | 0.92% $2.8M |
Parkman Healthcare Partners LLC Hedge Fund•Long/Short | 0.76% $6.9M |
Lansing Street Advisors RIA/Wealth | 0.48% $1.8M |
LexAurum Advisors, LLC RIA/Wealth | 0.32% $2.2M |
EAM Investors, LLC Long Only Manager | 0.25% $2.2M |
GMT CAPITAL CORP Hedge Fund•Long/Short | 0.10% $2.2M |
Discover hedge funds investing in PGEN

| Top Holding | Sector | Market Value | Weight |
|---|---|---|---|
Semiconductors Technology | $626.6M | 4.49% | |
Biotechnology Healthcare | $270.0M | 1.94% | |
Aerospace & Defense Industrials | $186.6M | 1.34% |
We use cookies for analytics. See our Privacy and Cookie Policy.